Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | Targeted therapy in TNBC

Peter Schmid, MD, PhD, FRCP, Barts Cancer Institute, London, UK gives an outline of targeted therapies for triple-negative breast cancer (TNBC) including neoadjuvant treatment in order to increase path CR. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.